Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
• To evaluate the lung bioavailability of B17MP (active metabolite of BDP) and formoterol as AUC0-t across two different dose strengths of CHF 1535 NEXThaler DPI (100/6 µg, 200/6 µg) with activated charcoal. • To evaluate the total systemic exposure to B17MP (active metabolite of BDP) and to Formoterol as AUC0-t across two different dose strengths of CHF 1535 NEXThaler DPI (100/6 µg, 200/6 µg) without activated charcoal.
Inclusion criteria
- Asthma